WESTLAKE BIOPARTNERS OPPORTUNITY FUND I, L.P. purchased 18.1% of their position (133.33K shares) of KYVERNA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1000.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/22/2025ACC: 0001104659-25-123596
→
10% Owner
Since Feb 2024
+133.33K
Net shares
Net buyer
$1000.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
133.33K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+133.33K
Price / share
$7.50
Trade value
$1000K
% of position
18.1%
12/18/2025
735.98K→869.32K
Total
Net shares
+133.33K
Net value
$1000K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/18/2025 | P · Purchase | +133.33K | $7.50 | $1000K | 18.1% | 735.98K | 869.32K |
| Total | +133.33K | $1000K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned3.79M
Total
3.79M indirect3.79M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.79M | Indirect |
| Total | 3.79M | 3.79M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported